{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:49:07Z","timestamp":1780472947518,"version":"3.54.1"},"reference-count":23,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"unspecified","delay-in-days":128,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2025,10,17]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterised by thrombosis, pregnancy complications and other non-thrombotic manifestations in the presence of antiphospholipid antibodies (aPL). Since its identification in 1983, research on APS has progressed, but no targeted therapies other than anticoagulation are yet available, with a mortality rate of 9.3% after a 10-year follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of the current systematic literature reviews (SLRs) is to identify and compare upregulated proteins in patients with thrombotic APS (tAPS) and non-aPL thrombosis, thereby providing useful insights into APS pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted two SLRs in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to identify proteins upregulated in tAPS and non-aPL-related thrombosis. Eligible studies included observational controlled research and focused on proteomics. Gene Ontology (GO) enrichment and network analyses were performed on the identified proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 108 and 209 records identified, seven and 13 were included in the SLR for tAPS and non-aPL thrombosis, respectively. The review identified 118 upregulated proteins in tAPS and 319 in non-aPL-related thrombosis. GO analysis revealed distinct biological process enrichment: platelet aggregation, platelet activation and blood coagulation were predominant in tAPS, while haemostasis, coagulation and wound healing were central in non-aPL-related thrombosis. Molecular functions in tAPS centred on receptor and protein complex binding, while enzymatic activities dominated in non-aPL thrombosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings highlight the central role of platelet-related processes in tAPS pathogenesis, distinguishing it from non-aPL thrombosis. By elucidating the unique proteomic and functional characteristics of tAPS, this study provides a foundation for future research into targeted therapies that address platelet involvement in APS pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2025-001751","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T10:30:16Z","timestamp":1762511416000},"page":"e001751","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Proteins upregulated in thrombotic antiphospholipid syndrome linked to platelet function in contrast with non-antiphospholipid-related thrombosis: insights from two systematic reviews"],"prefix":"10.1136","volume":"12","author":[{"given":"Silvia","family":"Mancuso","sequence":"first","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, University of Rome La Sapienza, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3358-5606","authenticated-orcid":false,"given":"Claudia","family":"Ciancarella","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, University of Rome La Sapienza, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5163-9807","authenticated-orcid":false,"given":"Luca","family":"Rapino","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, University of Rome La Sapienza, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Truglia","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, University of Rome La Sapienza, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Alessandri","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, University of Rome La Sapienza, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Conti","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, University of Rome La Sapienza, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"2026010700555058000_12.2.e001751.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2018.02.008"},{"key":"2026010700555058000_12.2.e001751.2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224609"},{"key":"2026010700555058000_12.2.e001751.3","doi-asserted-by":"publisher","DOI":"10.7326\/M19-0291"},{"key":"2026010700555058000_12.2.e001751.4","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/jth.14936","article-title":"Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis","volume":"18","author":"Ortel","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2026010700555058000_12.2.e001751.5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204838"},{"key":"2026010700555058000_12.2.e001751.6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/BOR.0000000000000932","article-title":"Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach","volume":"35","author":"Ambati","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"2026010700555058000_12.2.e001751.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.006"},{"key":"2026010700555058000_12.2.e001751.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.47.10.849"},{"key":"2026010700555058000_12.2.e001751.9","first-page":"261","article-title":"Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome","volume":"6","author":"Fanelli","year":"1997","journal-title":"Correlation with Thrombocytopenia and Anticardiolipin Antibodies Lupus"},{"key":"2026010700555058000_12.2.e001751.10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0037-1613033","article-title":"Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies","volume":"87","author":"Espinola","year":"2002","journal-title":"Thromb Haemost"},{"key":"2026010700555058000_12.2.e001751.11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M212655200"},{"key":"2026010700555058000_12.2.e001751.12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11684-015-0426-7","article-title":"Anti-\u03b22 glycoprotein I antibodies in complex with \u03b22 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2\u2019 and glycoprotein I b\u03b1","volume":"10","author":"Zhang","year":"2016","journal-title":"Front Med"},{"key":"2026010700555058000_12.2.e001751.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02310.x"},{"key":"2026010700555058000_12.2.e001751.14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1055\/s-0039-1685453","article-title":"Platelet Activation by Antiphospholipid Antibodies Depends on Epitope Specificity and is Prevented by mTOR Inhibitors","volume":"119","author":"Hollerbach","year":"2019","journal-title":"Thromb Haemost"},{"key":"2026010700555058000_12.2.e001751.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-053199"},{"key":"2026010700555058000_12.2.e001751.16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/rth2.12090","article-title":"Effects of anti-\u03b22GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity","volume":"2","author":"Ng","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"2026010700555058000_12.2.e001751.17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/cei.13248","article-title":"Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-\u03b22-GPI antibodies","volume":"196","author":"Capozzi","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"2026010700555058000_12.2.e001751.18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-554980"},{"key":"2026010700555058000_12.2.e001751.19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03101.x"},{"key":"2026010700555058000_12.2.e001751.20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/rheumatology\/keab475","article-title":"Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study","volume":"61","author":"Pardos-Gea","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026010700555058000_12.2.e001751.21","doi-asserted-by":"crossref","first-page":"152707","DOI":"10.1016\/j.semarthrit.2025.152707","article-title":"Molecular mechanisms underlying thrombosis in systemic lupus erythematosus - A Systematic review","volume":"72","author":"Larsen","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"2026010700555058000_12.2.e001751.22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/s-0041-1725057","article-title":"Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis","volume":"47","author":"Aibar","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"2026010700555058000_12.2.e001751.23","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000924","article-title":"Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"5","author":"Tektonidou","year":"2019","journal-title":"RMD Open"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2025-001751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:56:42Z","timestamp":1767776202000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2025-001751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,7]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/lupus-2025-001751"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2025-001751","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}